Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Uveal Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01473004
What this trial is testing

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Who this might be right for
Stage IV Uveal Melanoma
Thomas Jefferson University 48
Testing effectiveness (Phase 2)UnknownNCT05047276
What this trial is testing

Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma, Metastatic
José María Piulats Rodríguez 16
Testing effectiveness (Phase 2)Looking for participantsNCT07063875
What this trial is testing

Adding IL-2 to Tebentafusp to Eradicate Cancer Progression

Who this might be right for
Uveal MelanomaMetastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
St Vincent's Hospital, Sydney 8
Early research (Phase 1)Study completedNCT05169957
What this trial is testing

Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Who this might be right for
Melanoma, OcularMelanoma, CutaneousMetastatic Melanoma+2 more
University of Michigan Rogel Cancer Center 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT01979523
What this trial is testing

Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

Who this might be right for
Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT06940739
What this trial is testing

Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

Who this might be right for
Unresectable MelanomaMetastatic MelanomaOcular Melanoma
Iovance Biotherapeutics, Inc. 42
Not applicableUnknownNCT05889481
What this trial is testing

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma

Who this might be right for
Uveal Melanoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Study completedNCT01413191
What this trial is testing

Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+3 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT04904120
What this trial is testing

Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Who this might be right for
Melanoma (Skin)Melanoma Stage IVMelanoma, Uveal+1 more
Perspective Therapeutics 7
Early research (Phase 1)Study completedNCT02315066
What this trial is testing

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Who this might be right for
Neoplasms
Pfizer 174
Early research (Phase 1)Study completedNCT00705640
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Melanoma

Who this might be right for
Intraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin)
Craig L Slingluff, Jr 45
Testing effectiveness (Phase 2)WithdrawnNCT01328106
What this trial is testing

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

Who this might be right for
GNA11 Mutation-positive Metastatic MelanomaGNAQ Mutation-positive Metastatic MelanomaCancer+1 more
GlaxoSmithKline
Testing effectiveness (Phase 2)UnknownNCT01377025
What this trial is testing

Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Prof. Dr. med. Max. E. Scheulen 200
Early research (Phase 1)Study completedNCT03408587
What this trial is testing

CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)

Who this might be right for
Uveal MelanomaLiver Metastases
Viralytics 11
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Looking for participantsNCT07627698
What this trial is testing

Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma

Who this might be right for
Unresectable MelanomaMetastatic Cutaneous MelanomaMetastatic Uveal Melanoma
Beijing Biotech 36
Not applicableStudy completedNCT00897624
What this trial is testing

Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma

Who this might be right for
Intraocular Melanoma
Institut Curie 15
Large-scale testing (Phase 3)Study completedNCT02843386
What this trial is testing

Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

Who this might be right for
Uveal Melanoma
Institut Curie 302
Testing effectiveness (Phase 2)Study completedNCT00506142
What this trial is testing

Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma

Who this might be right for
Metastatic Malignant Uveal Melanoma
Spectrum Pharmaceuticals, Inc 54
Early research (Phase 1)Ended earlyNCT05341349
What this trial is testing

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown PrimaryMetastatic Malignant Neoplasm in the Brain+4 more
Emory University 1
Next Page